BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 24898325)

  • 1. Evaluation in mice of Brucella ovis attenuated mutants for use as live vaccines against B. ovis infection.
    Sancho P; Tejedor C; Sidhu-Muñoz RS; Fernández-Lago L; Vizcaíno N
    Vet Res; 2014 Jun; 45(1):61. PubMed ID: 24898325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brucella outer membrane complex-loaded microparticles as a vaccine against Brucella ovis in rams.
    Muñoz PM; Estevan M; Marín CM; Jesús De Miguel M; Jesús Grilló M; Barberán M; Irache JM; Blasco JM; Gamazo C
    Vaccine; 2006 Mar; 24(11):1897-905. PubMed ID: 16337315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and evaluation as vaccines in mice of Brucella melitensis Rev.1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis.
    Cloeckaert A; Jacques I; Grilló MJ; Marín CM; Grayon M; Blasco JM; Verger JM
    Vaccine; 2004 Jul; 22(21-22):2827-35. PubMed ID: 15246618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutants in the lipopolysaccharide of Brucella ovis are attenuated and protect against B. ovis infection in mice.
    Soler-Lloréns P; Gil-Ramírez Y; Zabalza-Baranguá A; Iriarte M; Conde-Álvarez R; Zúñiga-Ripa A; San Román B; Zygmunt MS; Vizcaíno N; Cloeckaert A; Grilló MJ; Moriyón I; López-Goñi I
    Vet Res; 2014 Jul; 45(1):72. PubMed ID: 25029920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of bp26 and bp26/omp31 B. melitensis Rev.1 deletion mutants against Brucella ovis in rams.
    Grilló MJ; Marín CM; Barberán M; de Miguel MJ; Laroucau K; Jacques I; Blasco JM
    Vaccine; 2009 Jan; 27(2):187-91. PubMed ID: 19007836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination.
    Cassataro J; Pasquevich KA; Estein SM; Laplagne DA; Velikovsky CA; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH; Goldbaum FA
    Vaccine; 2007 May; 25(22):4437-46. PubMed ID: 17442465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of whole cell and subcellular vaccines against Brucella ovis in rams.
    Blasco JM; Gamazo C; Winter AJ; Jiménez de Bagüés MP; Marín C; Barberán M; Moriyón I; Alonso-Urmeneta B; Díaz R
    Vet Immunol Immunopathol; 1993 Aug; 37(3-4):257-70. PubMed ID: 8236802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The candidate vaccine strain Brucella ovis ∆abcBA is protective against Brucella melitensis infection in mice.
    Costa LF; Cabello AL; Batista DFA; Chaki SP; de Figueiredo P; da Paixão TA; Rice-Ficht AC; Ficht TA; Santos RL
    Microbiol Immunol; 2020 Nov; 64(11):730-736. PubMed ID: 32965738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of possible correlates of protective response against Brucella ovis infection in rams immunized with the B. melitensis Rev 1 vaccine.
    Galindo RC; Muñoz PM; de Miguel MJ; Marin CM; Blasco JM; Gortazar C; Kocan KM; de la Fuente J
    Vaccine; 2009 May; 27(23):3039-44. PubMed ID: 19428917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection.
    Cassataro J; Estein SM; Pasquevich KA; Velikovsky CA; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH
    Infect Immun; 2005 Dec; 73(12):8079-88. PubMed ID: 16299302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological responses and protective efficacy against Brucella melitensis induced by bp26 and omp31 B. melitensis Rev.1 deletion mutants in sheep.
    Jacques I; Verger JM; Laroucau K; Grayon M; Vizcaino N; Peix A; Cortade F; Carreras F; Guilloteau LA
    Vaccine; 2007 Jan; 25(5):794-805. PubMed ID: 17070627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Brucella melitensis B115 as rough-phenotype vaccine against B. melitensis and B. ovis infections.
    Adone R; Francia M; Ciuchini F
    Vaccine; 2008 Sep; 26(38):4913-7. PubMed ID: 18675869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Brucella melitensis M5-90 wboA deletion strain is attenuated and enhances vaccine efficacy.
    Li ZQ; Shi JX; Fu WD; Zhang Y; Zhang J; Wang Z; Li TS; Chen CF; Guo F; Zhang H
    Mol Immunol; 2015 Aug; 66(2):276-83. PubMed ID: 25899866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal immunization with polymeric antigen BLSOmp31 using alternative delivery systems against Brucella ovis in rams.
    Díaz AG; Quinteros DA; Paolicchi FA; Rivero MA; Palma SD; Pardo RP; Clausse M; Zylberman V; Goldbaum FA; Estein SM
    Vet Immunol Immunopathol; 2019 Mar; 209():70-77. PubMed ID: 30885309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization with Brucella melitensis Rev 1 against Brucella ovis infection of rams.
    Blasco JM; Marín CM; Barberán M; Moriyón I; Díaz R
    Vet Microbiol; 1987 Sep; 14(4):381-92. PubMed ID: 3686824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A DNA vaccine coding for the Brucella outer membrane protein 31 confers protection against B. melitensis and B. ovis infection by eliciting a specific cytotoxic response.
    Cassataro J; Velikovsky CA; de la Barrera S; Estein SM; Bruno L; Bowden R; Pasquevich KA; Fossati CA; Giambartolomei GH
    Infect Immun; 2005 Oct; 73(10):6537-46. PubMed ID: 16177328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brucella melitensis 16MΔhfq attenuation confers protection against wild-type challenge in BALB/c mice.
    Zhang J; Guo F; Chen C; Li Z; Zhang H; Wang Y; Zhang K; Du G; Li Y; Wang J; Jian T; Wang Z
    Microbiol Immunol; 2013 Jul; 57(7):502-10. PubMed ID: 23647412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of particulate acellular vaccines against Brucella ovis infection in rams.
    Da Costa Martins R; Irache JM; Blasco JM; Muñoz MP; Marín CM; Jesús Grilló M; Jesús De Miguel M; Barberán M; Gamazo C
    Vaccine; 2010 Apr; 28(17):3038-46. PubMed ID: 19887131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residual virulence and immunogenicity of CGV26 and CGV2631 B. melitensis Rev. 1 deletion mutant strains in sheep after subcutaneous or conjunctival vaccination.
    Guilloteau LA; Laroucau K; Olivier M; Grillo MJ; Marin CM; Verger JM; Blasco JM
    Vaccine; 2006 Apr; 24(17):3461-8. PubMed ID: 16519974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Brucella melitensis H38ΔwbkF rough mutant protects against Brucella ovis in rams.
    Muñoz PM; Conde-Álvarez R; Andrés-Barranco S; de Miguel MJ; Zúñiga-Ripa A; Aragón-Aranda B; Salvador-Bescós M; Martínez-Gómez E; Iriarte M; Barberán M; Vizcaíno N; Moriyón I; Blasco JM
    Vet Res; 2022 Mar; 53(1):16. PubMed ID: 35236406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.